Adaptive design is an innovative approach that allows to conduct clinical trials more efficiently (with fewer patients, in shorter terms) or to increase the likelihood of demonstrating the effect of the drug. In studies with adaptation, the possibility of modifying a design or hypothesis is preliminary planned based on an intermediate analysis of the obtained data. What will we discuss in Webinar? Kinds and features of adaptive design Opportunities and risks of applying adapt

Since March 27th to April 26th Skolkovo Biotechnology and Medical Cluster, Skolkovo Open University and fundamental medicine faculty hold the educational program “Pharma’s Cool 2017”. The program include innovative and technical experience of leaders of big pharmaceutical companies. On March 31 Natalia Vostokova, IPHARMA Chief Operating Officer told about planning and design of clinical trials, supposal choice, statistics calculation and regulatory authorities specifics. Vale

IPHARMA article "Possibilities of adaptive design implementation in clinical trial of netx-in-class drugs" has been published in The Bulletin of the Scientific Center for Expert Evaluation of Medicinal Products has published (4, 2016). The article investigates the possibility of streamlining the methodology of clinical studies of next-in-class drugs by implementing an adaptive design. The results of clinical trials are illustrated by three investigational products of diffrent

Each year IPHARMA takes part in DIA (Drug Information Association) Global Conferences in Europe and the USA. During the event, participants share their views and knowledge and establish international contacts with potential partners and clients, which leads to a development in pharmaceutical industry. Within the frame of DIA 2016 52st Annual Meeting, which took place on June 26-30, 2016 in Pennsylvania Convention Center, Philadelphia, Natalia Vostokova (IPHARMA COO) presented

We are pleased to invite you to DIA 2016 52st Annual Meeting, which takes place in Pennsylvania Convention Center, Philadelphia, PA, June 26-30, 2016. Our booth number is 644. Natalia Vostokova, IPHARMA Chief Operating Officer, will present a poster on the following subject: Adaptive design in dose selection study of next-in-class NNRTI in the Exhibit Hall A, Wednesday, June 29 at 12:55 - 1:05 PM. DIA 2016 is the largest global interdisciplinary event that brings together 7,0

On June 2-3, 2016, IPHARMA will take part in the IV All-Russian Conference "Current issues of pre-clinical and clinical studies of drugs and medical devices". The Conference program includes plenary meetings and round table discussions on the ways to improve and enhance the quality of pre-clinical and clinical studies of drugs and medical devices. Participants: pharmaceutical companies, state educational and research institutions, regulatory authorities, contract organization

We are pleased to invite you to the Professional Poster Session #2B at 3:40 pm, 7 April 2016. Natalia Vostokova, IPHARMA Chief Operating Officer, will present a poster on the following subject: "Adaptive design in dose selection studies of next-in-class drugs" in the Innovation Theatre in the Exhibition Hall. We look forward to meet our partners and clients during the conference. Please, contact us to arrange the meeting: Anna Chernukha, +7 903 578 33 23, chea@ipharma.ru #ada